Epirubicin hydrochloride Good Manufacturer supply High Quality 56390-09-1
- Molecular Formula:C27H29NO11.HCl
- Molecular Weight:579.99
- Appearance/Colour:Orange-red crystalline solid
- Vapor Pressure:9.64E-28mmHg at 25°C
- Melting Point:185 °C dec
- Refractive Index:1.709
- Boiling Point:810.3 °C at 760 mmHg
- Flash Point:443.8 °C
- PSA：206.07000
- Density:1.61 g/cm3
- LogP:1.50360
Epirubicin hydrochloride (56390-09-1) Usage
Epirubicin is a stereoisomer of the antitumor anthracycline doxorubicin that undergoes β-glucuronidation, which partially detoxifies the dose-limiting side effects that are present with doxorubicin. Compared to doxorubicin, epirubicin is equally cytotoxic to HeLa cells (ID50s = 9 μM). When used either alone or in combination therapies, epirubicin has been shown to demonstrate high rates of complete or partial remission in various cancers including advanced ovary, lymphomas, breast, pancreas, gastric, hepatocellular carcinoma, head and neck tumors, and colorectal.
How to get the best price on Epirubicin hydrochloride?
Zibo Hangyu Biotechnology Development Co., Ltd is a quality supplier and manufacturer of Epirubicin hydrochloride . You can buy high quality, low price Epirubicin hydrochloride 56390-09-1 here.
Zibo Hangyu Biotechnology Development Co., Ltd. is a comprehensive chemical enterprise focusing on fine chemical products and pharmaceutical intermediates, integrating research and development, production and sales. The company is equipped with advanced equipment quality inspection and research center. At the same time, the company has excellent talents with rich experience in process development and quality control. To provide customers with total solutions from raw material processing to chemical synthesis systems. The company has established a standardized and perfect quality standard system to provide stable and high quality production and service.
Milestones
- 2012yearThe company was founded, began to engage in the production and supply of chemical raw materials
- 2014yearExpand the scale of production, pharmaceutical raw materials production workshop was established
- 2016yearCooperated with domestic and foreign chemical platforms to promote self-produced and high-end pharmaceutical intermediates
- 2019yearIn recent years to participate in the international pharmaceutical raw materials exhibitions
- 2023yearBusiness continues to expand, Production and Sales teams continue to grow
- 2026yearPlans to set up foreign branches
